You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 10, October 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Neurogenetics
 •Alert me on articles by topic

A Novel Type of Hereditary Motor and Sensory Neuropathy Characterized by a Mild Phenotype

Peter De Jonghe, MD, PhD; Vincent Timmerman, PhD; Eva Nelis, PhD; Els De Vriendt; Ann Löfgren, MSc; Chantal Ceuterick, PhD; Jean-Jacques Martin, MD, PhD; Christine Van Broeckhoven, PhD, DrSc

Arch Neurol. 1999;56:1283-1288.

Background  Three loci for autosomal dominant hereditary motor and sensory neuropathy type I (HMSN I) or Charcot-Marie-Tooth disease type 1 (CMT1) have been identified on chromosomes 17p11.2 (CMT1A), 1q21-q23 (CMT1B), and 10q21.1-q22.1 (designated here as CMT1D). The genes involved are peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ), and the early growth response element 2 (EGR2), respectively. Probably a fourth locus (CMT1C) exists since some autosomal dominant HMSN I families have been excluded for linkage with the CMT1A and CMT1B loci. Four loci for autosomal dominant hereditary motor and sensory neuropathy type II (HMSN II) or Charcot-Marie-Tooth disease type 2 (CMT2) have been localized on chromosomes 1p35-p36 (CMT2A), 3q13-q22 (CMT2B), 7p14 (CMT2D), and 3p (HMSN-P).

Objective  To describe the clinical, electrophysiologic, and neuropathological features of a novel type of Charcot-Marie-Tooth disease.

Patients and Methods  We performed linkage studies with anonymous DNA markers flanking the known CMT1 and CMT2 loci. Patients and their relatives underwent clinical neurologic examination and electrophysiologic testing. In the proband, a sural nerve biopsy specimen was examined.

Results  Linkage studies excluded all known CMT1 and CMT2 loci. The clinical phenotype is mild and almost all affected individuals remain asymptomatic. Electrophysiologic and histopathological studies showed signs of a demyelinating neuropathy, but the phenotype is unusual for either autosomal dominant HMSN I or HMSN II.

Conclusion  Our findings indicate that the HMSN in this family represents a novel clinical and genetic entity.


From the Laboratory of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology (VIB), Born-Bunge Foundation (BBS), University of Antwerp (UIA), Department of Biochemistry (Drs De Jonghe, Timmerman, Nelis, and Van Broeckhoven and Mss De Vriendt and Löfgren), the Department of Neurology, University Hospital Antwerp (UZA) (Drs De Jonghe and Martin), and Laboratory of Neuropathology, Born-Bunge Foundation (BBS) (Drs Ceuterick and Martin), Antwerpen, Belgium.


RELATED ARTICLES

Hereditary Motor and Sensory Neuropathy: The Plot Thickens
David Pleasure
Arch Neurol. 1999;56(10):1195.
EXTRACT | FULL TEXT  

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(10):1302-1303.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hereditary Motor and Sensory Neuropathy: The Plot Thickens
Pleasure
Arch Neurol 1999;56:1195-1195.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.